M. Thomas

1.5k total citations · 1 hit paper
20 papers, 1.1k citations indexed

About

M. Thomas is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, M. Thomas has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in M. Thomas's work include Melanoma and MAPK Pathways (9 papers), Cutaneous Melanoma Detection and Management (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). M. Thomas is often cited by papers focused on Melanoma and MAPK Pathways (9 papers), Cutaneous Melanoma Detection and Management (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). M. Thomas collaborates with scholars based in France, United States and United Kingdom. M. Thomas's co-authors include Caroline Robert, Émilie Routier, Lise Boussemart, Gorana Tomasic, Christine Mateus, H. Cazenave, Séverine Le Roy, Émilie Lanoy, Camille Hua and Matthieu Texier and has published in prestigious journals such as Nature, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

M. Thomas

19 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab

2015 503 citations Camille Hua, Lise Boussemart et al. JAMA Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Thomas France	8	758	503	238	172	89	20	1.1k
Nyam Kamsu-Kom France	10	615 0.8×	662 1.3×	101 0.4×	117 0.7×	58 0.7×	12	1.0k
J. Weiss United States	8	912 1.2×	550 1.1×	243 1.0×	141 0.8×	23 0.3×	8	1.2k
Lucia Festino Italy	18	880 1.2×	368 0.7×	375 1.6×	190 1.1×	26 0.3×	39	1.2k
J-Y Chen Taiwan	10	492 0.6×	384 0.8×	167 0.7×	66 0.4×	72 0.8×	12	914
J F Flores United States	9	565 0.7×	552 1.1×	123 0.5×	73 0.4×	49 0.6×	11	968
Virginia Picasso Italy	12	400 0.5×	314 0.6×	197 0.8×	101 0.6×	27 0.3×	16	661
Barbara Bodner United States	8	368 0.5×	445 0.9×	280 1.2×	204 1.2×	21 0.2×	9	824
Susan Korenchuk United States	13	348 0.5×	896 1.8×	107 0.4×	462 2.7×	53 0.6×	18	1.4k
Tomoyuki Momma Japan	23	539 0.7×	479 1.0×	341 1.4×	242 1.4×	35 0.4×	91	1.2k
Robert P. Whitehead United States	14	527 0.7×	285 0.6×	176 0.7×	189 1.1×	24 0.3×	38	824

Countries citing papers authored by M. Thomas

Since Specialization

Citations

This map shows the geographic impact of M. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Thomas more than expected).

Fields of papers citing papers by M. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Thomas. The network helps show where M. Thomas may publish in the future.

Co-authorship network of co-authors of M. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of M. Thomas. A scholar is included among the top collaborators of M. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Thomas. M. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Carman Man-Chung, Michael Oliphant, M. Thomas, et al.. (2024). Brca1 haploinsufficiency promotes early tumor onset and epigenetic alterations in a mouse model of hereditary breast cancer. Nature Genetics. 56(12). 2763–2775. 4 indexed citations

Thomas, M.. (2021). ON DUAL TECHNOLOGY INTEGRATION FOR EFFECTIVE TEACHING OF DIGITAL ACCOUNTING IN A TECHNOLOGY-RICH, ONLINE LEARNING CONTEXT. 2 indexed citations

Boussemart, Lise, Isabelle Girault, Hélène Malka-Mahieu, et al.. (2016). Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization. Cancer Research. 76(6). 1476–1484. 33 indexed citations

Mateus, Christine, Olaf Mercier, P. Dufour, et al.. (2016). Cancers secondaires sous immunothérapies dans un contexte de mélanome métastatique. Annales de Dermatologie et de Vénéréologie. 143(12). S365–S366. 1 indexed citations

Rhun, Émilie Le, Christine Mateus, Laurent Mortier, et al.. (2015). Traitement systémique des métastases cérébrales de mélanome. Cancer/Radiothérapie. 19(1). 48–54. 2 indexed citations

Hua, Camille, Lise Boussemart, Christine Mateus, et al.. (2015). Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab. JAMA Dermatology. 152(1). 45–45. 503 indexed citations breakdown →

Boussemart, Lise, Hélène Malka-Mahieu, Isabelle Girault, et al.. (2014). eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies. Nature. 513(7516). 105–109. 261 indexed citations

Izzedine, Hassane, Victor Gueutin, Christine Mateus, et al.. (2014). Kidney injuries related to ipilimumab. Investigational New Drugs. 32(4). 769–773. 133 indexed citations

Boussemart, Lise, Isabelle Girault, Christine Mateus, et al.. (2014). Abstract 934: BRAF inhibitors induce skin and extra-cutaneous tumors via paradoxical activation of the MAPK pathway: Molecular study of 66 tumors and visualization of BRAF/CRAF protein dimers. Cancer Research. 74(19_Supplement). 934–934. 1 indexed citations

10.

Gouvello, Sabine Le, Frédéric Charlotte, M. Thomas, et al.. (2014). Primary cutaneous aggressive epidermotropic CD8+ T‐cell lymphoma with KIR3DL2 and NKp46 expression in a human immunodeficiency virus carrier. Journal of Cutaneous Pathology. 42(3). 199–205. 5 indexed citations

11.

Mateus, Christine, Émilie Routier, Séverine Le Roy, et al.. (2014). Biomarker study evaluating the combination of dabrafenib (D) with trametinib (T) versus the combination after 8 weeks of monotherapy with dabrafenib or trametinib in patients with metastatic and unresectable stage IIIC or IV melanoma: GSK study 116613.. Journal of Clinical Oncology. 32(15_suppl). TPS9114–TPS9114. 4 indexed citations

12.

Robert, Caroline, Christina Mateus, Émilie Routier, et al.. (2013). Metastatic melanoma: New paradigms of treatment and new toxicities. European Journal of Cancer Supplements. 11(2). 278–280. 1 indexed citations

13.

Boussemart, Lise, Émilie Routier, Céu Mateus, et al.. (2013). Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients. Annals of Oncology. 24(6). 1691–1697. 137 indexed citations

14.

Coombes, R. Charles, Judith M. Bliss, Marc Espié, et al.. (2011). Randomized, Phase III Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin Alone in Postmenopausal Patients With Node-Positive Breast Cancer. Journal of Clinical Oncology. 29(24). 3247–3254. 12 indexed citations

15.

Thomas, M., H. Adamski, L. Misery, et al.. (2010). Physicians involved in the care of patients with high risk of skin cancer should be trained regarding sun protection measures: evidence from a cross sectional study. Journal of the European Academy of Dermatology and Venereology. 25(1). 19–23. 18 indexed citations

16.

Haro, Luc de, et al.. (2000). Intoxications par champignons expérience du centre anti-poisons de Marseille en 1994 et 1998. Journal de Pédiatrie et de Puériculture. 13(1). 58–61. 8 indexed citations

17.

Noël, D., et al.. (1979). Hémochromatose et déficit en pyruvate kinase.. 130(12). 6 indexed citations

18.

Thomas, M.. (1976). Curability of breast cancer. BMJ. 1(6010). 645.2–645. 4 indexed citations

19.

Thomas, M., et al.. (1973). Hépatites chroniques. Rapport de l'antigene australia et des anticorps anti-tissus avec l'aspect histologique et l'evolution. A propos de 75 cas. 2(6).

20.

Gresser, Ion, C. Bourali, J A Levy, Delphine Fontaine, & M. Thomas. (1969). Prolongation de la survie des souris inoculees avec des cellules tumorales et traitees avec des preparations d'interferons.. The Mouseion at the JAXlibrary (Jackson Laboratory). 994. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact